SpyGlass Pharma, Inc. (SGP)

NASDAQ: SGP · Real-Time Price · USD

25.78

-0.42 (-1.60%)

Aug 17, 2026, 4:00 PM EDT - Market closed

SpyGlass Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Aug '26 Aug 17, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Market Capitalization	862	-	-
Market Cap Growth	-	-	-
Enterprise Value	630	-	-

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Aug '26 Aug 17, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Debt / Equity Ratio	0.01	0.02	0.32
Net Debt / Equity Ratio	-1.00	-1.00	-1.02
Net Debt / EBITDA Ratio	3.81	2.59	0.46
Net Debt / FCF Ratio	4.68	3.16	0.52
Quick Ratio	24.89	12.57	2.14
Current Ratio	25.06	12.67	2.23
Return on Equity (ROE)	-	-67.70%	-
Return on Assets (ROA)	-	-37.23%	-
Return on Capital Employed (ROCE)	-26.50%	-38.60%	-174.30%

Yields

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Aug '26 Aug 17, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Buyback Yield / Dilution	-708.11%	-23.98%	-

SEC Filings: 10-K · 10-Q